[A new application for well-known pharmaceutics--losartan and fenofibrate as potential remedies against gout?]

Dtsch Med Wochenschr. 2014 Mar;139(12):608. doi: 10.1055/s-0033-1360078. Epub 2014 Mar 11.

[Article in German]

Authors

Julia Saar¹, W Kirch¹

Affiliation

¹ Institut für Klinische Pharmakologie, Unabhängige Arzneimittelberatung für Patienten (UPD), Medizinische Fakultät der Technischen Universität Dresden.

PMID: 24619720
DOI: 10.1055/s-0033-1360078

No abstract available

Publication types

Letter

MeSH terms

Angiotensin II Type 1 Receptor Blockers / adverse effects
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Fenofibrate / adverse effects
Fenofibrate / therapeutic use*
Gout / blood
Gout / drug therapy*
Gout Suppressants / adverse effects
Gout Suppressants / therapeutic use*
Humans
Hypolipidemic Agents / adverse effects
Hypolipidemic Agents / therapeutic use*
Losartan / adverse effects
Losartan / therapeutic use*
Off-Label Use
Treatment Outcome
Uric Acid / blood

Substances

Angiotensin II Type 1 Receptor Blockers
Gout Suppressants
Hypolipidemic Agents
Uric Acid
Losartan
Fenofibrate